Even with available tests and treatment, preventable diseases place a tremendous pressure on health systems, communities and economies, especially in low-and-middle income countries.
Since 2020 we proudly partnered with (RED) to increase awareness and drive systemic changes so that people can access reliable testing and equitable healthcare. Working together with creative collaborators, our partnership spotlights the continued need to invest in diagnostics which is pivotal in making significant progress towards universal health coverage.
Sustainable healthcare financing mechanisms remain at the core of Universal Health Coverage which ensures that all people, regardless of where they live, receive the best standard of care. In turn, testing and laboratories are the backbone of strong healthcare systems and need strategic investments directed towards prevention to deliver the highest impact for people and communities. Behind every test are years of investments in research and development, policy changes, advocacy, infrastructure development and capacity building.
Reliable testing and innovative diagnostics technologies are crucial to support timely diagnosis and continuous disease management that enable deadly diseases elimination and fighting future pandemics. The global fight against HIV/AIDS is a clear example of the value of diagnostics tools and continuous investments to expand access to them.
Specifically in sub-Saharan Africa, we are committed to creating greater awareness about the importance and value of diagnostics building on the HIV backbone to strengthen laboratory and health systems for even broader impact.
Through our partnership with (RED), we aim to connect more people to testing so they know their status and access the right treatment to stay alive and thrive. This means access to diagnostics can spread so that disease cannot. Let us work together to show the world how access to reliable testing can change communities and build the future of a generation.
If you can’t test you can’t treat and you can’t save lives.
Accurate testing is the backbone of ending any pandemic. A reliable HIV test provides empowering, life-saving information. Moreover, leveraging diagnostics to expand screening of related infectious diseases such as HPV, tuberculosis and hepatitis is critical to reducing mortality and supporting global elimination targets.
With treatment, a person’s viral load can be suppressed to the point where it’s unlikely the virus will be transmitted to others. An early positive diagnosis for a pregnant woman can provide life-saving information to help her stay healthy and ensure her child is born HIV-free.
Testing doesn’t end once a person discovers their HIV status. Regular viral load monitoring of the virus arms people with the information they need to stay healthy and empowers them to pursue their dreams.
(RED) has been a driving force in the fight against global health threats since 2006. This organization, founded by Bono and Bobby Shriver, has been instrumental in driving awareness and delivering funding to fight AIDS and the injustices that enable pandemics to thrive.
As a proud member of the (RED) partnership, we're committed to fighting pandemics and are resolute in our dedication to using our resources and expertise to make a lasting impact.
Founded by Bono & Bobby Shriver in 2006 to fight AIDS, (RED) partners with the world’s most iconic brands and people to create products and experiences that raise money, heat and urgency for global health crises.
Every action you take with (RED) saves lives.
To date, (RED) has generated over $760 million for the Global Fund, helping more than 290 million people. (RED) funding supports life-saving programs that empower health workers and provide testing, treatment and care in places where injustice has enabled pandemics to thrive.
Together, Roche and (RED) are committed to eliminating preventable and treatable diseases, a vision that's deeply intertwined with our core values. As global leaders in healthcare and advocacy, we are determined to use our joint expertise and resources to improve healthcare access, enhance diagnostic testing, and further educate communities about the significance of healthcare diagnostics.
While our work has already touched millions of lives, we recognise that many communities are still unfamiliar with the global fight against AIDS. In 2024 we aim to bridge this gap, reaching new audiences and raising awareness about the vital role diagnostics play in preventing and treating diseases. We're not just providing information; we're inciting a call to action. Our campaign's purpose is to create a sense of urgency, inspire involvement, and invite everyone to join us in our mission to end the threat of AIDS.
Alongside (RED) , we've seen first-hand the transformative effects of this global initiative. With the combined efforts of its partners, (RED) has generated more than $760 million for the Global Fund, a leading entity in global health funding. This invaluable contribution has positively impacted over 290 million lives, helping to strengthen health systems and support life-saving programs in communities hit hardest by pandemics.
Our partnership with (RED) allows us to bolster our shared mission in novel and impactful ways. By leveraging the power of (RED)'s iconic brand relationships and global platforms, we can extend the reach of our educational initiatives and generate even more support for our cause.
References
The Lancet Commission on diagnostics: transforming access to diagnostics. 2021. Available on .
UNAIDS. 2024. Global HIV statistics. Available on
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.